chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The reporter stated that, their facility had not been able to download the digital data logger, they had been put on hold at the moment. There had been no power outages that would have impacted the Moderna vaccine.  It was reported that, the facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. The reporter did not have any questions and wanted to report this to Moderna.  The reporter stated that no adverse reactions were reported by any patients.  No treatment medications were reported.
Holds L leg stiffly-will not bend at knee or bear weight. Shot areas on LT w/induration, no erythema or specific pt tenderness. F/up in ortho if not walking or bearing wt by 1/9/06.
Information has been received from a physician concerning a 6 year old female who on 07/05/96 was vaccinated with varicella virus vaccine live in her right arm. On 09/22/01, in the morning, the pt experienced clinical varicella. Additional information has been requested.
C\O headache, nausea/vomiting, monitored x2 hours, sent home with guardian. TC made to parent just getting over sore throat/sinus infection.
This case was reported by a other health professional and described the occurrence of pain in a female patient who received BOOSTRIX (batch number 95L3P, expiry date 1st April 2016). In October 2014, the patient received BOOSTRIX. On an unknown date, unknown after receiving BOOSTRIX, the patient experienced pain. On an unknown date, the outcome of the pain was not recovered/not resolved. It was unknown if the reporter considered the pain to be related to BOOSTRIX. Additional information: patient experienced pain after vaccination with BOOSTRIX, got vaccinated in October 2014 and still continues to feel pain. No other vaccines given on same day as BOOSTRIX vaccine. patient is not able to exercise due to arm pain.
Two weeks after getting the second dose of the vaccine, I had two episodes of vertigo.  I have no history of vertigo.  I also developed  bouncy vision where it looks like things are bouncing up and down or moving side to side when I walk or turn my head.  It has not resolved.  I am scheduled with a neurologist on 5/4/21 to determine if I have any vestibular damage.  It is possible this is permanent and at this current time it is very disabling. I am not sure if this is related to the vaccine but I thought it best to report it in case other reports of this come up.
So, my elbow started hurting and the pain move toward my wrist. My hand started getting inflamed. Some point after that my shoulder starting getting pain in it and than my upper arm started hurting as well. I have no frametime of when all of this started hurting. I just know that I would be in a lot of pain. My shoulder started getting worse and worse over a period of time. My shoulder blade and neck on the right side is very painful. I can't do a lot of things that consist of me using my right side.
Noted left deltoid site was red and warm to the touch. Starts at shoulder and comes down midway.
01/15/2022 Started noticing heart flutters, different times of the day, during activity and inactivity, several times a day. I had a tiny bit of chest pressure with flutters. Started out infrequently, then accelerated. After flutters woke me up last week, I called the cardiologist and have an appointment today.
Patient requested a Covid-19 Pfizer vaccine and he filled out the consent form and we verbally counseled the patient what the vaccine was.  He was given the CDC vaccine card and told to come back in 21 days.  When we ran his claim, his insurance said he already received the doses at a different facility.  We told him after his vaccination and he said he forgot he had already gotten 2 doses at a different place in january.  So the vaccine he got was a 3rd dose today,
Persistent rash after pfizer vaccine says rash started 1 am Thursday after vaccine Tuesday last week. Rash has been on arms, legs, breasts. No difficulty swallowing, breathing at baseline. Went to urgent care after speaking to physician 4/17 and was given topical steroid and referred to allergist. Called back yesterday b/c sx persisted- Prednisone 50mg started yesterday, by HCP and sx are improving. Pt reports long standing hx of GI issues- chronic constipation which causes N/V. She is having a complete workup with GI for this. Vomited once Thursday night when she was constipated, took laxative as recommended by GI and no sx since then, but does get loose stools from laxative. Rash persists on the right arm inner elbow, left elbow rash improving, improving on the legs. She reports previous brain fog is improving. She has chronic fatigue, unchanged for over a year. She reports loss of tastes x 3 days. Denies other URI sx. chronic back pain, no change. She reports hx of recurrent sx like this following new medications, never with vaccines. She will be f/u w/  allergist for further evaluation.
Mouth sore; throat sores; persistent cough; This is a spontaneous report from a non-contactable consumer, the patient. A unknown gender patient of unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: UNKNOWN) via an unspecified route of administration on 05May2021 at 00:00, as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021 at 01:00, the patient experienced mouth sore, throat sore and persistent cough. The events did not result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as the result of adverse events. The clinical outcome of the events mouth sore, throat sore and persistent cough were not recovered at the time of report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
miniature shocks like pins needles  that goes up his back and into his neck; This is a spontaneous report from a contactable consumer. A 59-year-old male patient received second dose of  BNT162B2 (BNT162B2) via an unspecified route of administration, administered in Arm Right on 22Feb2021 (Batch/Lot Number: EN5318) as single dose for covid-19 immunization. The patient's medical history includes dental work in Dec2020. There were no concomitant medications. The patient was previously administered first dose with BNT162B2 for covid-19 vaccination (Lot number EL9261, expiration unknown, Right Arm, (First dose). The patient also previously used novocaine (he had dental work in Dec2020 and stated that they only gave him Novocaine). The patient experienced miniature shocks like pins needles that goes up his back and into his neck on 28Feb2021. Reporter states that he is experiencing little miniature shocks like pins needles that goes up his back and into his neck. It has never been below his waist. They are not in his arms, legs, or head. It is like is annoying pricking like when you have been in contact with fiber glass. It does not hurt or itch, it is a tingling sensation. He never had it before or any blood or breathing issues. He said that he has not had any other medications, a change in diet, or been exposed to anything hazardous. He said that he had dental work in Dec2020 and stated that they only gave him Novocaine and it did not affect him like this. The outcome of the event was not recovered.
69 patients received expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (69 patients received expired vaccine) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (69 patients received expired vaccine). On 06-Jan-2022, EXPIRED PRODUCT ADMINISTERED (69 patients received expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.  There was a failure to change the expiration date of Moderna Lot 012H21B when it was shipped. The original was kept -15 to -25 and then shipped and kept refrigerate. This lot was shipped on 06-Dec-2021 and the new expiration date should have been 05-Jan-2022 due to the refrigeration of the vaccine. The error was caught on 11-Jan-2022 when a new shipment was received. Immediately the vaccine given was stopped and 69 patients had received expired vaccine since 06-Jan-2022.
Due to various circumstances the patient never received her second Moderna primary series Covid-19 vaccine; covid 19; Vaccine administered at inappropriate site; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (covid 19), PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Vaccine administered at inappropriate site) and PRODUCT ADMINISTRATION INTERRUPTED (Due to various circumstances the patient never received her second Moderna primary series Covid-19 vaccine) in a 16-month-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.  On 19-Oct-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Oct-2022, the patient experienced PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Vaccine administered at inappropriate site). In December 2022, the patient experienced COVID-19 (covid 19). On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (Due to various circumstances the patient never received her second Moderna primary series Covid-19 vaccine). At the time of the report, COVID-19 (covid 19), PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Vaccine administered at inappropriate site) and PRODUCT ADMINISTRATION INTERRUPTED (Due to various circumstances the patient never received her second Moderna primary series Covid-19 vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Oct-2022, SARS-CoV-2 test: Positive.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No other adverse reactions are reported.  No treatment medications were reported.
Sore throat; Pink eye; Ear pain; COVID tongue; Was very sick; Coughing; >35 days since first dose of vaccination has passed; Not feeling good; Had pain in arm for weeks; Body aches; Bronchitis; Had respiratory problems; COVID-19; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 17-May-2021 and was forwarded to Moderna on 17-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BRONCHITIS (Bronchitis), RESPIRATORY DISORDER (Had respiratory problems), COVID-19 (COVID-19), OROPHARYNGEAL PAIN (Sore throat) and EYE COLOR CHANGE (Pink eye) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure and Cholesterol.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced BRONCHITIS (Bronchitis), RESPIRATORY DISORDER (Had respiratory problems), OROPHARYNGEAL PAIN (Sore throat), EYE COLOR CHANGE (Pink eye), EAR PAIN (Ear pain), GLOSSODYNIA (COVID tongue), ILLNESS (Was very sick), COUGH (Coughing), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (>35 days since first dose of vaccination has passed), VACCINATION COMPLICATION (Not feeling good), VACCINATION SITE PAIN (Had pain in arm for weeks) and MYALGIA (Body aches). The patient was treated with ZINC ongoing since an unknown date at a dose of 1 dosage form; VITAMIN C [ASCORBIC ACID] ongoing since an unknown date at a dose of 1 dosage form; VIT D [VITAMIN D NOS] ongoing since an unknown date at a dose of 1 dosage form; IRON ongoing since an unknown date at a dose of 1 dosage form; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and PREDNISONE for Coughing and Bronchitis, at an unspecified dose and frequency. At the time of the report, BRONCHITIS (Bronchitis), RESPIRATORY DISORDER (Had respiratory problems), COVID-19 (COVID-19), OROPHARYNGEAL PAIN (Sore throat), EYE COLOR CHANGE (Pink eye), EAR PAIN (Ear pain), GLOSSODYNIA (COVID tongue), ILLNESS (Was very sick), COUGH (Coughing), VACCINATION COMPLICATION (Not feeling good), VACCINATION SITE PAIN (Had pain in arm for weeks) and MYALGIA (Body aches) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (>35 days since first dose of vaccination has passed) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications of the patient included, blood pressure and cholesterol medications. No treatment medications provided by the reporter.
With Dose #1, within 24 hours of receiving the dose on 9/10/21 at 4:00pm, I had extremity numbness from my elbows to my fingertips, my knees to my toes, along with tingling in my extremities along with my face and nose tingling as well, I had nausea and diarrhea.  With Dose #2 within 2 hours of receiving the dose on 9/30/21 at 6:45pm, i had continued extremity numbness and tingling along with my face and nose, as well as sharp pains in the center of my eyes, nausea, and vomiting.   It is 10/20/21 and those symptoms have remained.
Patient at first experienced severe arm soreness, fever, chills, rash, breathing issues and headaches. A couple weeks after the vaccine the patient started experiencing chest pains, chest tightness, and more frequent shortness of breath.
~ 3-5" p Gardasil 0.5 ml IM L deltoid, patient had ~ 5 seconds of loss of consciousness, generalized shaking of torso & extremities. No p ictal confusion.
Client received the Moderna COVID-19 Vaccine at the mass clinic site for The Health Department. After approx. 5 mins, client approached writer with complaints of HA, nausea and dizziness. Client was assisted into wheelchair, then assisted onto cot. Client moaning with complaints of severe HA, body aches and nausea and experienced dry heaves. Client is pale. Client's position hindered obtaining a blood pressure. Client became more pale, weaker and not responding to verbal command/questions from the nurses.  The nurses directed someone to call 911 at 10:07am. Nurses attempted to rouse client to get her to talk.  She then stated "oh my head" "oh, my neck hurts", still not opening her eyes or aware of RN speaking to her.  She then drooped on the bed with head into chin.  At this point the team decided to administer Epi Pen 0.3 mg/0.3mL.  It was visually inspected as clear and date checked. Epi Pen administered at 10:08am by RN. BP at 10:09am 102/80, pulse 88. Client then yelled and became responsive, eyes opened and asking for water. Client positioned on her side due to nausea. 10:11am p80. Client responds when roused. Nausea and severe HA continues. Color improved. Client reports taking medication for hypertension and high cholesterol. 10:14am BP 144/80, p76. Client rubbing thigh where Epi Pen was administered. States her "body burns". AT 10:18a, Fire Emergency Responders arrived and assumed care of client. Client transported to ER by emergency responders at 10:25am.  Client was accompanied by her husband, who was being driven by son. He will meet client at  ER.
No mental comfort; Not developing any Antibodies; This spontaneous case was reported by a consumer and describes the occurrence of EMOTIONAL DISTRESS (No mental comfort) and ADVERSE EVENT (Not developing any Antibodies) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PREGABALIN (LYRICA), ATORVASTATIN, ASPIRIN [ACETYLSALICYLIC ACID], CYANOCOBALAMIN (VITAMIN B 12 [CYANOCOBALAMIN]), VITAMIN C [ASCORBIC ACID], BACLOFEN, METOPROLOL and VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EMOTIONAL DISTRESS (No mental comfort) and ADVERSE EVENT (Not developing any Antibodies). At the time of the report, EMOTIONAL DISTRESS (No mental comfort) and ADVERSE EVENT (Not developing any Antibodies) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: no antibodies (abnormal) No antibodies in system and has an abnormal protein which is called monoclonal protein and it could be a multiple myeloma precursor.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient tested for COVID-19 but no results. No treatment was provided.    Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Contact information updated
Patient will not receive second dose; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient will not receive second dose) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient will not receive second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient will not receive second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  No concomitant medication was provided.
1 day after immunization, pt noted redness, swelling, tenderness, and itching at injection site on right thigh.  Mildly antalgic gait. Received motrin at home for pain (afebrile).  On the next day, presented back to primary care office due to significant enlargement of areas of redness, swelling, and tenderness.  Area was >10-15 cm in diameter, red, warm, indurated, with pain to palpation.  Pt was afebrile (T 99F orally) but tachycardic to 130's (on prior visit, HR had been in 90s), although she was well-appearing.  Sent to ER for evaluation of possible cellulitis due to rapid spread and possible systemic Sx.  IV ancef given, pt was started on oral Keflex and advised to follow with PCP.  Follow up call placed by LPN on next day--parent reported swelling had improved though redness still present.  Appointment scheduled for follow up though pt did not arrive to visit.
Woke up day after shot with an extreme headache, arm pain at shot site, general lethargy.  No appetite.  Had extreme headache all day, like a very bad hangover.  Ate a small lunch at noon.  Took 2 650 mg tablets of Acetaminophen at 3:00PM.  Threw up at 4:00PM.  Went to bed at 4:30PM, woke up at 6:30 PM with extreme nausea.  Threw up rest of stomach contents over next 40 minutes.  At 8:00 PM started sipping 7UP and eating saltine crackers.  Condition improved, sore arm and nausea dissipated.
feeling a little sick after her second vaccination; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (feeling a little sick after her second vaccination) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (feeling a little sick after her second vaccination). At the time of the report, VACCINATION COMPLICATION (feeling a little sick after her second vaccination) had not resolved.            No relevant concomitant medications were reported. No treatment information was provided.
Patent got very tired, couldn't stay awake. She refuses EMT. We released her to her mother after helping the mom put her in her car. Mother said she was taking her to the urgent care. Vitals were pace 75, bp 124/102. She just couldn't wake up.